Acumen Pharmaceuticals, Inc. - Common Stock

Share · US00509G2093 · ABOS (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

12.12.2025 23:37

Current Prices from Acumen Pharmaceuticals, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	ABOS	USD	12.12.2025 23:37	2,09 USD	0,13 USD +6,37 %

Share Float & Liquidity

Free Float 78,89 %

Shares Float 47,79 M

Shares Outstanding 60,57 M

Company Profile for Acumen Pharmaceuticals, Inc. - Common Stock Share

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Get up to date insights from finAgent about Acumen Pharmaceuticals, Inc. - Common Stock

Company Data

Name Acumen Pharmaceuticals, Inc. - Common Stock

Company Acumen Pharmaceuticals, Inc.

Symbol ABOS

Website https://acumenpharm.com

Primary Exchange

NASDAQ

ISIN US00509G2093

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Daniel J. O'Connell

Market Capitalization 128 Mio

Country United States of America

Currency USD

Employees 0,1 T

Address 427 Park Street, 22902 Newton

IPO Date 2021-07-01

Ticker Symbols

Name	Symbol
NASDAQ	ABOS

More Shares

Investors who hold Acumen Pharmaceuticals, Inc. - Common Stock also have the following shares in their portfolio:

Chenghe Acquisition III Co. - Warrants Share

CORAZON CAPITAL V838 MONOCEROS CORP - CLASS A Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog